National and State Vaccination Coverage Among Adolescents Aged 13-17 Years -- United States, 2011

Dorell, Christina; Stokley, Shannon; Yankey, David; Jeyarajah, Jenny; MacNeil, Jessica; Markowitz, Lauri
August 2012
MMWR: Morbidity & Mortality Weekly Report;8/31/2012, Vol. 61 Issue 34, p671
The article presents the findings of the assessment of national and state vaccination coverage among adolescents in the U.S. aged 13 to 17 years from 2010-2011 using data from the National Immunization Survey-Teen (NIS-Teen). It has found an increase in vaccination coverage for diphtheria, acellular pertussis (Tdap) and meningococcal conjugate, as well as increase in human papillomavirus (HPV) vaccine among females.


Related Articles

  • ACIP Releases 2016 Childhood Immunization Recommendations. SAVOY, MARGOT // American Family Physician;2/15/2016, Vol. 93 Issue 4, p321 

    The article discusses the 2016 immunization recommendations for children released by the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention in the U.S. It recommends that children with a history of sexual assault should be vaccinated against HPV...

  • Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV. Di Mario, Simona; Basevi, Vittorio; Lopalco, Pier Luigi; Balduzzi, Sara; D’Amico, Roberto; Magrini, Nicola; D'Amico, Roberto // Journal of Immunology Research;8/25/2015, Vol. 2015, p1 

    Background: When the bivalent and the quadrivalent HPV vaccines were marketed they were presented as having comparable efficacy against cervical cancer. Differences between the vaccines are HPV types included and formulation of the adjuvant.Method: A systematic review...

  • Cost-Effectiveness Analysis of the Bivalent and Quadrivalent Human Papillomavirus Vaccines from a Societal Perspective in Colombia. Aponte-González, Johanna; Fajardo-Bernal, Luisa; Diaz, Jorge; Eslava-Schmalbach, Javier; Gamboa, Oscar; Hay, Joel W. // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Objective:To compare costs and effectiveness of three strategies used against cervical cancer (CC) and genital warts: (i) Screening for CC; (ii) Bivalent Human Papillomavirus (HPV) 16/18 vaccine added to screening; (iii) Quadrivalent HPV 6/11/16/18 vaccine added to screening. Methods:A...

  • IMMUNIZATION.  // MPR - Physician Assistants' Edition;Spring2015, Vol. 22 Issue 1, p101 

    The article reviews several drugs for immunization including Boostrix from GlaxoSmithKline, Adacel from Sanofi Pasteur and Flucelvax from Novartis.

  • HPV vaccine catch-up drive falters. Praities, Nigel // Pulse;2/10/2010, Vol. 70 Issue 4, p9 

    The article reports that general practitioners (GPs) conducts a round of human pappilomavirus (HPV) vaccination in young men in Great Britain, since it shows a dissatisfactory number received into a full three doses over the catch-up campaign.

  • Parental concerns common barrier against adolescent HPV vaccination.  // Infectious Disease News;Dec2013, Vol. 26 Issue 12, p43 

    The article discusses a study focusing on factors affecting adolescents' vaccination against human papillomavirus (HPV) published in a 2013 issue of the "JAMA Pediatrics" journal.

  • ACIP Releases 2016 Adult Immunization Recommendations. SAVOY, MARGOT // American Family Physician;2/15/2016, Vol. 93 Issue 4, p317 

    The article discusses the 2016 adult immunization recommendations released by the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention in the U.S. The recommendations include vaccinations against nonavalent human papillomavirus (HPV),...

  • Vaccination coverage in US adolescents increased in 2014.  // PharmacoEconomics & Outcomes News;Aug2015, Vol. 734 Issue 1, p29 

    The article reports on the findings of the 2014 National Immunization Survey-Teen by the U.S. Centers for Disease Control and Prevention (CDC) which indicate an increase of vaccination coverage in adolescents in 2014. The survey found an improvement in human papillomavirus vaccine coverage, and...

  • Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands. Minthe Bousema, Josefien Cornelie; Ruitenberg, Joost // International Journal of Health Policy & Management;Nov2015, Vol. 4 Issue 11, p757 

    Invasive meningococcal disease (IMD) is a severe bacterial infectious disease with high mortality and morbidity rates worldwide. In recent years, industrialised countries have implemented vaccines targeting IMD in their National Immunisation Programmes (NIPs). In 2002, the Netherlands...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics